The effect of CPAP masks on hemodynamic parameters, arterial blood gas and pulmonary complications in patients after open heart surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT138902013146N2

Enrollment

Registered

2016-08-18

Start date

2015-12-10

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: plural effusion. Condition 2: Atelectasis. Condition 3: pneumonia. Condition 4: Hemodynamic. Pleural effusion in conditions classified elsewhere Pulmonary collapse Bacterial pneumonia, not elsewhere classified Other and unspecified disorders of circulatory system

Interventions

Intervention 1: . After the extubation, a continuous positive airway pressure mask (with a force of 5 cmH2o) used for patients in the intervention group (30 minutes every eight hours for five consecut

Treatment - Devices

. After the extubation, a continuous positive airway pressure mask (with a force of 5 cmH2o) used for patients in the intervention group (30 minutes every eight hours for five consecutive times).

control group:NO treat ment

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: age > 18 years; having an elective of surgery; undergoing cardiopulmonary bypass (CPB) during cardiac surgery; having an EF over 40%; having at least a chest tube in the pleural cavity; being under mechanical ventilation for less than 12 hours after the surgery. Exclusion criteria: no need for medications such as epinephrine, dopamine, and dobutamine at the start of the study; lacking a definite diagnosis of COPD and asthma.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Diastolic BP. Timepoint: pre and 10 min post Intervention. Method of measurement: monitor.;Heart Rate. Timepoint: pre and 10 min post Intervention. Method of measurement: monitor.;Centeral Venous Pressure. Timepoint: pre and 10 min post Intervention. Method of measurement: monitor.;Atelectasy. Timepoint: end of Study. Method of measurement: CXRay.;Systolic BP. Timepoint: pre and 10 min post Intervention. Method of measurement: monitor.;Plural Effusion. Timepoint: end of Study. Method of measurement: CXRay.;Mean arterial pressure. Timepoint: pre and 10 min post Intervention. Method of measurement: monitor.;Pneumonia. Timepoint: end of Study. Method of measurement: CXRay.	—

Measure

Time frame

Diastolic BP. Timepoint: pre and 10 min post Intervention. Method of measurement: monitor.;Heart Rate. Timepoint: pre and 10 min post Intervention. Method of measurement: monitor.;Centeral Venous Pressure. Timepoint: pre and 10 min post Intervention. Method of measurement: monitor.;Atelectasy. Timepoint: end of Study. Method of measurement: CXRay.;Systolic BP. Timepoint: pre and 10 min post Intervention. Method of measurement: monitor.;Plural Effusion. Timepoint: end of Study. Method of measurement: CXRay.;Mean arterial pressure. Timepoint: pre and 10 min post Intervention. Method of measurement: monitor.;Pneumonia. Timepoint: end of Study. Method of measurement: CXRay.

—

Secondary

Measure	Time frame
Ejection Fraction. Timepoint: end of study. Method of measurement: Echocardiography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIsmail Azizi-Fini

Kashan University of Medical Sciences

azizi-es@kaums.ac.ir, azizifinies@yahoo.com+98 31 5554 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026